Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 242KB)
Why become a member?
 

Fibromyalgia study involves medication and conversation

Friday 12 March 2010

TabletsHealthCanal.com reports:

Fibromyalgia Study Involves Medication and Conversation

INDIANAPOLIS — The Indiana University Fibromyalgia Clinical Research Center is evaluating communication as a therapeutic tool in treating the often painful yet common disease.

This is the third in a continuing series of research studies for fibromyalgia entitled Drug and Talk Therapy for Fibromyalgia.

The IU center is conducting this study to better understand how talk therapies, such as education and cognitive behavioral therapy, can improve the therapeutic benefits of medications for fibromyalgia.

Savella®, also known as milnacipran, is an FDA approved drug for fibromyalgia. The safety and efficacy of Savella has been established in two nationwide clinical studies involving more than 2,000 patients with fibromyalgia. Since Savella has already been shown to be effective when used in isolation to treat fibromyalgia, IU researchers are conducting the study to determine whether combination treatment (Savella + talk therapy) is more effective than Savella alone or talk therapy alone.

Participants are randomly assigned to receive either Savella or a placebo (sugar pill) and will receive either cognitive behavior therapy or an educational phone series.

Those interested in learning more about this study should contact the Fibromyalgia Clinical Research Center at 317-278-3971.

The study is funded by National Institutes of Health.

# # #

Media Contact:

Mary Hardin
(317) 274-7722
(317) 695-4090 (cell)
mhardin@iupui.edu

The article originally appeared here.

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus

Previous Previous Page